Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Aytu Biopharma stock

Learn how to easily invest in Aytu Biopharma stock.

Aytu Biopharma Inc is a drug manufacturers-specialty & generic business based in the US. Aytu Biopharma shares (AYTU) are listed on the NASDAQ and all prices are listed in US Dollars. Aytu Biopharma employs 175 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Aytu Biopharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AYTU – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aytu Biopharma stock price (NASDAQ: AYTU)

Use our graph to track the performance of AYTU stocks over time.

Aytu Biopharma shares at a glance

Information last updated 2022-01-16.
Latest market close$1.28
52-week range$1.31 - $11.76
50-day moving average $1.80
200-day moving average $3.77
Wall St. target price$17.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.07

Buy Aytu Biopharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aytu Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aytu Biopharma price performance over time

Historical closes compared with the close of $1.28 from 2022-01-18

1 week (2022-01-11) -11.11%
1 month (2021-12-17) -20.00%
3 months (2021-10-18) -49.61%
6 months (2021-07-19) -69.30%
1 year (2021-01-19) -83.29%
2 years (2020-01-17) 60.00%
3 years (2019-01-18) 21.90%
5 years (2017-01-19) 15.32%

Aytu Biopharma financials

Revenue TTM $74 million
Gross profit TTM $29.2 million
Return on assets TTM -14.54%
Return on equity TTM -80.8%
Profit margin -110.57%
Book value $4.02
Market capitalisation $38 million

TTM: trailing 12 months

Aytu Biopharma share dividends

We're not expecting Aytu Biopharma to pay a dividend over the next 12 months.

Have Aytu Biopharma's shares ever split?

Aytu Biopharma's shares were split on a 1:10 basis on 8 December 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu Biopharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aytu Biopharma shares which in turn could have impacted Aytu Biopharma's share price.

Aytu Biopharma share price volatility

Over the last 12 months, Aytu Biopharma's shares have ranged in value from as little as $1.31 up to $11.76. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu Biopharma's is -0.3654. This would suggest that Aytu Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aytu Biopharma has bucked the trend.

Aytu Biopharma overview

Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021.

Frequently asked questions

What percentage of Aytu Biopharma is owned by insiders or institutions?
Currently 6.271% of Aytu Biopharma shares are held by insiders and 17.707% by institutions.
How many people work for Aytu Biopharma?
Latest data suggests 175 work at Aytu Biopharma.
When does the fiscal year end for Aytu Biopharma?
Aytu Biopharma's fiscal year ends in June.
Where is Aytu Biopharma based?
Aytu Biopharma's address is: 373 Inverness Parkway, Englewood, CO, United States, 80112
What is Aytu Biopharma's ISIN number?
Aytu Biopharma's international securities identification number is: US0547548745
What is Aytu Biopharma's CUSIP number?
Aytu Biopharma's Committee on Uniform Securities Identification Procedures number is: 054754106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site